Zenta Tsuchihashi, PhD, has extensive experience in the field of oncology and translational science, currently serving as Senior Director of Translational Science at Daiichi Sankyo, Inc., focusing on DS-8201/ENHERTU and ADC Safety. Previous positions include Senior Medical Science Liaison in oncology at AstraZeneca, Director of Medical Affairs - Oncology at Daiichi Sankyo, Biomarker Program Leader for Afinitor at Novartis, and Group Leader for Immuno-Oncology Biomarkers at Bristol-Myers Squibb. Zenta Tsuchihashi holds a post-doctoral fellowship in Biochemistry from Stanford University and a Bachelor's degree in Pharmaceutical Sciences from The University of Tokyo.
2020 - present
2011